# A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

> **NCT03833700** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Eisai Co., Ltd.** · enrollment: 70 (estimated)

## Conditions studied

- Solid Neoplasms
- Colorectal Neoplasms
- Gastrointestinal Tumors

## Interventions

- **DRUG:** E7386

## Key facts

- **NCT ID:** NCT03833700
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-03-05
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03833700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03833700, "A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03833700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*